Director, HTA, Value & Evidence – Obesity Early Pipeline

• Provide strategic input into clinical trial designs and analysis to enable successful negotiations, reimbursement, and appropriate patient access
• Lead development of evidence generation strategies for Internal Medicine assets, focusing on obesity and non-obesity products
• Coordinate input from local country and regional teams and incorporate it into global market access evidence strategies
• Lead design and execution of global HEOR studies, including network meta-analyses, non-interventional studies, and economic models, from concept through publication
• Develop patient-reported outcomes strategies and incorporate humanistic and economic endpoints into clinical trials
• Oversee customer-facing dissemination of HEOR materials in accordance with regulatory guidance and internal SOPs
• Develop strategic partnerships and research collaborations with external experts, healthcare policymakers, payers, and academic and community settings
• Manage health economics and outcomes research to generate data supporting patient access to Pfizer’s early-pipeline products
• Manage multiple complex projects, including contracting, budgeting, vendor management, stakeholder engagement, and technical deliverables
• Guide junior team members and lead cross-functional collaboration across medical, clinical, commercial, access strategy, pricing, statistics, country, and regional teams

• Graduate degree required, such as MSc, MPH, or PhD
• 7+ years of experience with an MSc, MPH, or MBA degree; or 5+ years with a PharmD, PhD, or DrPH in HEOR or related fields
• Experience in health economics, epidemiology, health services research, or another research-focused public health field
• Expertise in HEOR strategy, evidence development, health services research methods, health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies
• Knowledge of registries and observational study design, implementation, analysis, and interpretation
• Ability to independently manage complex non-interventional study projects
• Knowledge and understanding of the drug development process
• Excellent oral and written English communication skills
• Ability to assess project and program value, align work with business priorities, and prioritize accordingly
• Strong project management abilities, including contracting, budgeting, and vendor management
• Ability to manage multiple complex projects involving significant budgets, competing deadlines, shifting priorities, and stakeholder engagement
• Experience leading cross-functional teams and guiding junior team members
• Ability to function effectively within a matrix organization
• Organized and detail-oriented, proactive, and able to anticipate and resolve needs
• Comfortable responding to unexpected demands and tight timelines
• Ability to travel domestically and internationally
• Ability to work in all U.S. time zones
• Candidates must be authorized to be employed in the U.S. by any employer
• Permanent work authorization in the United States required; U.S. work visa sponsorship is unavailable
• Preferred: knowledge and experience in obesity/internal medicine, HTA organizations, early-stage development, clinical trials, patient-reported outcomes, early economic models, global launch support, and generative AI tools

Demonstrates expertise in Health Economics and Outcomes Research (HEOR) with a focus on evidence generation strategies, project management, and cross-functional collaboration. Proficient in developing patient-reported outcomes and managing complex clinical trial designs to support patient access and reimbursement strategies.